Troy Ignelzi
2019 - scPharmaceuticals
In 2019, Troy Ignelzi earned a total compensation of $296K as Former Chief Financial Officer at scPharmaceuticals, a 67% decrease compared to previous year.
Compensation breakdown
| Salary | $66,538 |
|---|---|
| Other | $229,482 |
| Total | $296,020 |
Ignelzi received $229.5K in other compensation, accounting for 78% of the total pay in 2019.
Ignelzi also received $66.5K in salary.
Rankings
In 2019, Troy Ignelzi's compensation ranked 12,955th out of 13,971 executives tracked by ExecPay. In other words, Ignelzi earned more than 7.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,955 out of 13,971 | 7th |
Division Manufacturing | 5,259 out of 5,695 | 8th |
Major group Chemicals And Allied Products | 2,055 out of 2,194 | 6th |
Industry group Drugs | 1,768 out of 1,880 | 6th |
Industry Pharmaceutical Preparations | 1,305 out of 1,392 | 6th |
Source: SEC filing on April 27, 2020.
Ignelzi's colleagues
We found two more compensation records of executives who worked with Troy Ignelzi at scPharmaceuticals in 2019.
News
Karuna Therapeutics CEO Steven Paul's 2021 pay jumps 48% to $13M
April 27, 2022
Karuna Therapeutics CEO Steven Paul's 2020 pay slips 11% to $8.9M
April 27, 2021
Karuna Therapeutics CEO Steven Paul's 2019 pay jumps 932% to $10M
April 29, 2020
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020
scPharmaceuticals CEO John Tucker's 2018 pay falls 25% to $1.5M
April 30, 2019